Press Releases about Sigyn Therapeutics Inc![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Regulatory Compliance
![]()
Sigyn Therapeutics Announces Third Quarter 2022 Financial Results
November 15, 2022
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() ![]()
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
September 14, 2022
Via NewMediaWire
Topics
Death
Exposures
Death
![]() ![]() ![]() ![]() ![]() ![]()
Sigyn Therapeutics Appoints Alexander S. Yevzlin, MD, FASN to Its Scientific Advisory Board
March 09, 2022
Via NewMediaWire
Topics
Death
Exposures
Death
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|